Reexamination Sample Clauses

Reexamination. A. A bargaining unit member who has failed the written portion of an examination may, after three (3) months following the date of said examination, be scheduled for retesting, provided the request is made pursuant to the provisions of Section 10.05.
Sample 1Sample 2
AutoNDA by SimpleDocs
Reexamination. [***] Microsoft will also cause to be filed with the United States Patent and Trademark Office notifications in the current reexamination proceedings of the Patents-In-Suit indicating that Microsoft Corporation will not participate in those reexamination proceedings. [***] INDICATES PORTIONS OF THIS EXHIBIT THAT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. IN WITNESS WHEREOF, VirnetX Inc. and Microsoft Corporation, being fully authorized and empowered to bind themselves to this Agreement, have caused this Agreement to be made and executed by duly authorized officers as of the Effective Date. VIRNETX INC. MICROSOFT CORPORATION Name: /s/ Xxxxxxx Xxxxxx Name: /s/ Xxxxx X Xxxx Title: President, Chairman and CEO Title: Corp Vice President Date: 5/14/2010 Date: 5-14-2010 Exhibit A Certain Licensed Patents Country App. No. Filing date Patent No. Issue Date WO PCT/US99/25325 10/29/1999 AU 00/14553 10/29/1999 761,388 09/18/2003 CA 2,349,519 10/29/1999 EP 99971606.1 10/29/1999 1125419 08/26/2009 EP-GB 99971606.1 10/29/1999 1125419 08/26/2009 EP-DE 99971606.1 10/29/1999 1125419 08/26/2009 EP-FR 99971606.1 10/29/1999 1125419 08/26/2009 EP-IT 46406/BE/2009 10/29/1999 1125419 08/26/2009 JP 2000-580350 10/29/1999 4,451,556 02/05/2010 JP 2009-246033 10/29/1999 US 09/429,643 10/29/1999 7,010,604 03/07/2006 US 10/401,551 03/31/2003 7,133,930 11/07/2006 US 11/301,022 12/13/2005 US 11/839,937 08/16/2007 US 09/429,643 02/15/2000 6,502,135 12/31/2002 WO PCT/US01/04340 02/12/2001 EP 01910528.7 02/12/2001 JP 2001-560062 02/12/2001 US 10/082,164 02/26/2002 6,618,761 09/09/2003 US 10/401,888 03/31/2003 6,907,473 06/14/2005 US 10/082,285 02/26/2002 6,834,310 12/21/2004 US 10/259,494 09/30/2002 7,490,151 02/10/2009 US 11/839,969 08/16/2007 US 11/924,460 10/25/2007 WO PCT/US99/25323 10/29/1999 AU 00/16003 10/29/1999 765914 01/15/2004 CA 2,349,520 10/29/1999 EP 99958693.6 10/29/1999 JP 2000-580354 10/29/1999 US 09/558,209 04/26/2000 WO PCT/US01/13261 04/25/2001 EP 01932629.7 04/25/2001 EP 06014499.5 04/25/2001 EP 06014500.0 04/25/2001 HK 07109112.7 08/21/2007 HK 07109113.6 08/21/2007 JP 2001-583006 04/25/2001 US 10/702,486 11/07/2003 7,188,180 03/06/2007 US 11/679,416 02/27/2007 US 11/839,987 08/16/2007 US 10/702,522 11/07/2003 6,839,759 01/04/2005 US 10/702,580 11/07/2003 6,826,616 11/30/2004 US 09/558,210 04/26/2000 WO PCT/US01/13260 04/25/2001 EP 01932628.9 04/25/2001 1284079 01/18/2006 EP CH 019...
Sample 1
Reexamination. [***] Microsoft will also cause to be filed with the United States Patent and Trademark Office notifications in the current reexamination proceedings of the Patents-In-Suit indicating that Microsoft Corporation will not participate in those reexamination proceedings. [***] Indicates portions of this exhibit that have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.
Sample 1

Related to Reexamination

  • Patent The development of patentable inventions or discoveries is not the primary purpose of the research activities of the faculty. Employees have no obligation to seek patent protection for the results of scientific work nor to modify research to enhance patentability.

  • Applications To the extent that any provision of any Application related to any Letter of Credit is inconsistent with the provisions of this Section 3, the provisions of this Section 3 shall apply.

  • Prosecution of Patents (a) The Licensor shall be solely responsible for preparing, prosecuting and maintaining the BENTLEY Patents.

  • Patent Applications It is understood by the parties that, pursuant to the Baylor Technology Transfer Agreement, MAS has the initial responsibility for filing, prosecution and maintenance of Patents and Patent Applications covering the Baylor Technology. The parties agree that, as between MAS and CTI, MAS shall be responsible for deciding whether and how to file, prosecute and maintain the Patents and Patent Applications, provided that:

  • Patents As to any patentable subject matter contained in the deliverables, the Contractor agrees to disclose such patentable subject matter to the City. Further, if requested by the City, the Contractor agrees to assign and, if necessary, cause each of its employees to assign the entire right, title, and interest to specific inventions under such patentable subject matter to the City and to execute, acknowledge, and deliver and, if necessary, cause each of its employees to execute, acknowledge, and deliver an assignment of letters patent, in a form to be reasonably approved by the City, to the City upon request by the City.

  • Filing of Patent Applications Each Party will make timely decisions regarding the filing of Patent Applications on the CRADA Subject Inventions made solely by its employee(s), and will notify the other Party in advance of filing. Collaborator will have the first opportunity to file a Patent Application on joint CRADA Subject Inventions and will notify PHS of its decision within sixty (60) days of an Invention being reported or at least thirty (30) days before any patent filing deadline, whichever occurs sooner. If Collaborator fails to notify PHS of its decision within that time period or notifies PHS of its decision not to file a Patent Application, then PHS has the right to file a Patent Application on the joint CRADA Subject Invention. Neither Party will be obligated to file a Patent Application. Collaborator will place the following statement in any Patent Application it files on a CRADA Subject Invention: “This invention was created in the performance of a Cooperative Research and Development Agreement with the [INSERT into Agency’s model as appropriate: National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention], an Agency of the Department of Health and Human Services. The Government of the United States has certain rights in this invention.” If either Party files a Patent Application on a joint CRADA Subject Invention, then the filing Party will include a statement within the Patent Application that clearly identifies the Parties and states that the joint CRADA Subject Invention was made under this CRADA.

  • Prosecution Hospital shall be responsible for the preparation, filing, prosecution and maintenance of all patent applications and patents included in Patent Rights. Company shall reimburse Hospital for Patent Costs incurred by Hospital relating thereto in accordance with Section 4.2.

  • Provisional Application Upon signature of this Compact, and until this Compact has entered into force in accordance with Section 7.3, the Parties will provisionally apply the terms of this Compact; provided that, no MCC Funding, other than Compact Implementation Funding, will be made available or disbursed before this Compact enters into force.

  • Continuations Borrower may, on any Eurodollar Banking Day, upon notice given to the Administrative Agent not later than 9:00 a.m. (California time) on the third Eurodollar Banking Day prior to the date of the proposed Continuation and subject to the provisions of Sections 3.5 and 3.6, Continue all or any portion of the Eurodollar Rate Advances outstanding under a Facility having the same Eurodollar Period; provided that any such Continuation shall be made only on the last day of a Eurodollar Period for such Eurodollar Rate Advances, no Continuation of Eurodollar Rate Advances shall be in an amount less than $1,000,000 and no Continuation of any Eurodollar Rate Advances shall result in more than five (5) separate Eurodollar Periods being outstanding under the Revolving Facility. Each such notice of Continuation shall be made pursuant to a Request for Continuation/Conversion and shall, within the restrictions specified above, specify (i) the date of such Continuation, (ii) the aggregate amount and category of, and the Eurodollar Period for, the Advances being Continued and (iii) the duration of the initial Eurodollar Period for the Eurodollar Rate Advances subject to such Continuation. Each notice of Continuation shall be irrevocable and binding on Borrower.

  • Patents and Patent Applications To the Company’s knowledge, all patents and patent applications owned by or licensed to the Company or under which the Company has rights have been duly and properly filed and maintained; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the USPTO in connection with such applications; and the Company is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which could reasonably be expected to preclude the grant of a patent in connection with any such application or could reasonably be expected to form the basis of a finding of invalidity with respect to any patents that have issued with respect to such applications.

Time is Money Join Law Insider Premium to draft better contracts faster.